MeVis Medical Solutions AG
FSX:M3V.DE
24.4 (EUR) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 17.342 | 18.762 | 16.214 | 17.131 | 18.073 | 16.758 | 18.54 | 16.121 | 16.014 | 13.091 | 14.617 | 13.347 | 13.678 | 14.291 | 13.869 | 10.844 | 7.892 | 8.342 |
| Cost of Revenue
| 0.445 | 0.747 | 0.437 | 0.626 | 0.457 | 0.474 | 0.506 | 6.153 | 0.612 | 0.634 | 0.683 | 0.535 | 0.712 | 0 | 0.459 | 0.367 | 0.65 | 0.427 |
| Gross Profit
| 16.897 | 18.015 | 15.777 | 16.505 | 17.616 | 16.284 | 18.034 | 9.968 | 15.402 | 12.457 | 13.934 | 12.812 | 12.966 | 14.291 | 13.41 | 10.477 | 7.242 | 7.915 |
| Gross Profit Ratio
| 0.974 | 0.96 | 0.973 | 0.963 | 0.975 | 0.972 | 0.973 | 0.618 | 0.962 | 0.952 | 0.953 | 0.96 | 0.948 | 1 | 0.967 | 0.966 | 0.918 | 0.949 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 3.417 | 3.576 | 3.455 | 3.486 | 4.798 | 4.276 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0.442 | 0.444 | 0.73 | 0.684 | 0.548 | 0.157 | 0.242 | 0 | 0.805 | 0.338 | 0.398 | 0.533 | 0 | 0.69 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0 | 0.043 | 0.112 | 0 | 0 | 0 | 0 | 0.015 | 0.015 | 0.061 | 0.072 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 0.442 | 0.444 | 0.773 | 0.796 | 0.548 | 0.157 | 0.242 | 1.991 | 0.82 | 0.353 | 0.459 | 0.605 | 0 | 0.69 | 0 | 0 | 0 | 0 |
| Other Expenses
| 0.314 | 11.201 | 9.977 | 9.838 | 9.927 | 9.197 | 9.761 | 0.271 | 9.768 | 8.174 | 9.407 | 9.196 | 14.608 | 19.028 | 11.777 | 9.812 | 6.746 | 3.174 |
| Operating Expenses
| 11.992 | 11.645 | 10.75 | 10.634 | 10.475 | 9.354 | 10.003 | 5.175 | 10.588 | 8.527 | 9.866 | 9.801 | 14.608 | 19.718 | 11.777 | 9.812 | 6.746 | 3.174 |
| Operating Income
| 5.077 | 7.88 | 5.25 | 5.806 | 8.165 | 6.694 | 7.962 | 4.793 | 4.47 | 3.89 | 4.026 | 2.975 | -1.642 | -5.427 | 1.633 | 0.665 | 0.487 | 4.477 |
| Operating Income Ratio
| 0.293 | 0.42 | 0.324 | 0.339 | 0.452 | 0.399 | 0.429 | 0.297 | 0.279 | 0.297 | 0.275 | 0.223 | -0.12 | -0.38 | 0.118 | 0.061 | 0.062 | 0.537 |
| Total Other Income Expenses Net
| -0.043 | -0.004 | -0.619 | -0.012 | -0.01 | 0.563 | -0.794 | -0.236 | 0.483 | 1.054 | -0.21 | -0.616 | -0.346 | -0.712 | -0.465 | -0.321 | 0 | 0 |
| Income Before Tax
| 5.034 | 7.877 | 4.631 | 5.794 | 8.156 | 7.257 | 7.168 | 4.557 | 4.953 | 4.944 | 3.816 | 2.359 | -2.915 | -5.607 | 1.168 | 2.706 | 0.487 | 4.477 |
| Income Before Tax Ratio
| 0.29 | 0.42 | 0.286 | 0.338 | 0.451 | 0.433 | 0.387 | 0.283 | 0.309 | 0.378 | 0.261 | 0.177 | -0.213 | -0.392 | 0.084 | 0.25 | 0.062 | 0.537 |
| Income Tax Expense
| 0.114 | 0.087 | 0.085 | 0.09 | 0.085 | 0.086 | 1.546 | 3.041 | -1.782 | 1.231 | 0.135 | 0.195 | 1.177 | 2.742 | 0.77 | 0.592 | 0.355 | 1.542 |
| Net Income
| 4.92 | 7.789 | 4.546 | 5.704 | 8.071 | 7.171 | 5.622 | 4.567 | 6.735 | 3.713 | 3.681 | 2.164 | -4.092 | -8.349 | 0.398 | 2.114 | 0.132 | 2.935 |
| Net Income Ratio
| 0.284 | 0.415 | 0.28 | 0.333 | 0.447 | 0.428 | 0.303 | 0.283 | 0.421 | 0.284 | 0.252 | 0.162 | -0.299 | -0.584 | 0.029 | 0.195 | 0.017 | 0.352 |
| EPS
| 2.7 | 4.28 | 2.5 | 3.13 | 4.43 | 3.94 | 3.09 | 2.51 | 3.76 | 2.16 | 2.14 | 1.26 | -2.38 | -4.89 | 0.23 | 1.21 | 0.17 | 5.44 |
| EPS Diluted
| 2.7 | 4.28 | 2.5 | 3.13 | 4.43 | 3.94 | 3.09 | 2.48 | 3.72 | 2.16 | 2.14 | 1.26 | -2.38 | -4.89 | 0.23 | 1.21 | 0.17 | 5.44 |
| EBITDA
| 5.172 | 7.974 | 5.375 | 5.974 | 8.421 | 8.417 | 8.462 | 6.551 | 7.127 | 6.853 | 6.124 | 5.719 | 3.489 | 3.985 | 5.005 | 4.119 | 1.067 | 5.06 |
| EBITDA Ratio
| 0.298 | 0.425 | 0.332 | 0.349 | 0.466 | 0.502 | 0.456 | 0.406 | 0.445 | 0.523 | 0.419 | 0.428 | 0.255 | 0.279 | 0.361 | 0.38 | 0.135 | 0.607 |